Drug · DIN 02514931
EVRYSDI
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 19, 2021; first marketed May 19, 2021.
- Drug Identification Number (DIN)
- 02514931
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Oral
- Therapeutic class (ATC)
- Risdiplam M09AX10
- Class
- Human
- Record last updated
- May 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISDIPLAM | 0.75 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 14, 2021: NOC 25680New Drug Submission (NDS)
Other DINs named EVRYSDI
- DIN 02560747 · Marketed